BridgeBio Pharma, Inc. (BBIO)

68.22 +0.08 (+0.12%) USD  |  NASDAQ  |  Feb 23, 12:15
More

BridgeBio Pharma Current Tax Payable (Quarterly)

Current Tax Payable (Quarterly) Chart

View Current Tax Payable (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Tax Payable (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Tax Payable (Quarterly) Range, Past 5 Years

View Current Tax Payable (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Tax Payable (Quarterly) Benchmarks

View Current Tax Payable (Quarterly) Benchmarks
Start Trial
Insmed, Inc. --
Mirum Pharmaceuticals, Inc. --
Cogent Biosciences, Inc. --
Alnylam Pharmaceuticals, Inc. --
Sarepta Therapeutics, Inc. Upgrade